HealthTree Logo
search more_vert
App Logo
close
person Sign In / Create Account

Daniel DeAngelo, MD, PhD

Hematologist Oncologist, Professor of Medicine at Harvard Medical School, Chief, Division of Leukemia

23 years treating AML

Clinical Expertise

Dr. DeAngelo's current research interests include novel immunotherapeutic approaches to the treatment of acute myelogenous leukemia and myelodysplasia. He is currently developing leukemia tumor vaccines from patients with AML or advanced myelodysplasia and will be assaying for immunological and serological responses.

Location

Dana Farber Cancer Institute: 450 Brookline Ave, Boston, MA 02215, USA

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Jazz Pharmaceuticals
AbbVie
Amgen
Genentech
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube